{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T09:35:14Z","timestamp":1779183314166,"version":"3.51.4"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,8,17]],"date-time":"2013-08-17T00:00:00Z","timestamp":1376697600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s00535-013-0862-6","type":"journal-article","created":{"date-parts":[[2013,8,16]],"date-time":"2013-08-16T12:47:26Z","timestamp":1376657246000},"page":"1121-1134","source":"Crossref","is-referenced-by-count":47,"title":["Toll-like receptor 4 activation in Barrett\u2019s esophagus results in a strong increase in COX-2 expression"],"prefix":"10.1007","volume":"49","author":[{"given":"Romy E.","family":"Verbeek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter D.","family":"Siersema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiebo J.","family":"Ten Kate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kees","family":"Fluiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhonda F.","family":"Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank P.","family":"Vleggaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Bus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jantine W. P. M.","family":"van Baal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,17]]},"reference":[{"key":"862_CR1","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s10620-005-2451-x","volume":"50","author":"PG Guillem","year":"2005","unstructured":"Guillem PG. How to make a Barrett esophagus: pathophysiology of columnar metaplasia of the esophagus. Dig Dis Sci. 2005;50:415\u201324.","journal-title":"Dig Dis Sci"},{"key":"862_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/978-3-642-03503-6_4","volume":"185","author":"A Nicholson","year":"2011","unstructured":"Nicholson A, Jankowski J. Acid reflux and oesophageal cancer. Recent Results Cancer Res. 2011;185:65\u201382.","journal-title":"Recent Results Cancer Res"},{"key":"862_CR3","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/jnci\/djr203","volume":"103","author":"S Bhat","year":"2011","unstructured":"Bhat S, Coleman HG, Yousef F, Johnston BT, McManus DT, Gavin AT, et al. Risk of malignant progression in Barrett\u2019s esophagus patients: results from a large population-based study. J Natl Cancer Inst. 2011;103:1049\u201357.","journal-title":"J Natl Cancer Inst"},{"key":"862_CR4","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1136\/gutjnl-2011-300730","volume":"61","author":"TK Desai","year":"2012","unstructured":"Desai TK, Krishnan K, Samala N, Singh J, Cluley J, Perla S, et al. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett\u2019s oesophagus: a meta-analysis. Gut. 2012;61:970\u20136.","journal-title":"Gut"},{"key":"862_CR5","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1056\/NEJMoa1103042","volume":"365","author":"F Hvid-Jensen","year":"2011","unstructured":"Hvid-Jensen F, Pedersen L, Drewes AM, Sorensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett\u2019s esophagus. N Engl J Med. 2011;365:1375\u201383.","journal-title":"N Engl J Med"},{"key":"862_CR6","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1158\/1055-9965.EPI-10-0012","volume":"19","author":"H Pohl","year":"2010","unstructured":"Pohl H, Sirovich B, Welch HG. Esophageal adenocarcinoma incidence: are we reaching the peak? Cancer Epidemiol Biomarkers Prev. 2010;19:1468\u201370.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"862_CR7","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1136\/gut.2004.063685","volume":"54","author":"EM Soest van","year":"2005","unstructured":"van Soest EM, Dieleman JP, Siersema PD, Sturkenboom MC, Kuipers EJ. Increasing incidence of Barrett\u2019s oesophagus in the general population. Gut. 2005;54:1062\u20136.","journal-title":"Gut"},{"key":"862_CR8","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1056\/NEJMoa022343","volume":"347","author":"JB Hulscher","year":"2002","unstructured":"Hulscher JB, van Sandick JW, de Boer AG, Wijnhoven BP, Tijssen JG, Fockens P, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347:1662\u20139.","journal-title":"N Engl J Med"},{"key":"862_CR9","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1053\/j.gastro.2005.07.026","volume":"129","author":"JW Baal van","year":"2005","unstructured":"van Baal JW, Milano F, Rygiel AM, Bergman JJ, Rosmolen WD, van Deventer SJ, et al. A comparative analysis by SAGE of gene expression profiles of Barrett\u2019s esophagus, normal squamous esophagus, and gastric cardia. Gastroenterology. 2005;129:1274\u201381.","journal-title":"Gastroenterology"},{"key":"862_CR10","first-page":"63","volume":"30","author":"JW Baal van","year":"2008","unstructured":"van Baal JW, Milana F, Rygiel AM, Sondermeijer CM, Spek CA, Bergman JJ, et al. A comparative analysis by SAGE of gene expression profiles of esophageal adenocarcinoma and esophageal squamous cell carcinoma. Cell Oncol. 2008;30:63\u201375.","journal-title":"Cell Oncol."},{"key":"862_CR11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/sj.onc.1210908","volume":"27","author":"M Fukata","year":"2008","unstructured":"Fukata M, Abreu MT. Role of Toll-like receptors in gastrointestinal malignancies. Oncogene. 2008;27:234\u201343.","journal-title":"Oncogene"},{"key":"862_CR12","doi-asserted-by":"crossref","unstructured":"Ioannou S, Voulgarelis M. Toll-like receptors, tissue injury, and tumourigenesis. Mediators Inflamm. 2010: pii: 581837","DOI":"10.1155\/2010\/581837"},{"key":"862_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1124\/pr.109.001073","volume":"61","author":"LA O\u2019Neill","year":"2009","unstructured":"O\u2019Neill LA, Bryant CE, Doyle SL. Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer. Pharmacol Rev. 2009;61:177\u201397.","journal-title":"Pharmacol Rev"},{"key":"862_CR14","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.4049\/jimmunol.174.8.4453","volume":"174","author":"MT Abreu","year":"2005","unstructured":"Abreu MT, Fukata M, Arditi M. TLR signaling in the gut in health and disease. J Immunol. 2005;174:4453\u201360.","journal-title":"J Immunol"},{"key":"862_CR15","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.coph.2009.09.006","volume":"9","author":"M Fukata","year":"2009","unstructured":"Fukata M, Abreu MT. Pathogen recognition receptors, cancer and inflammation in the gut. Curr Opin Pharmacol. 2009;9:680\u20137.","journal-title":"Curr Opin Pharmacol"},{"key":"862_CR16","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1053\/j.gastro.2007.09.008","volume":"133","author":"M Fukata","year":"2007","unstructured":"Fukata M, Chen A, Vamadevan AS, Cohen J, Breglio K, Krishnareddy S, et al. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology. 2007;133:1869\u201381.","journal-title":"Gastroenterology"},{"key":"862_CR17","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1189\/jlb.0607358","volume":"83","author":"SC Gribar","year":"2008","unstructured":"Gribar SC, Anand RJ, Sodhi CP, Hackam DJ. The role of epithelial Toll-like receptor signaling in the pathogenesis of intestinal inflammation. J Leukoc Biol. 2008;83:493\u20138.","journal-title":"J Leukoc Biol"},{"key":"862_CR18","doi-asserted-by":"publisher","first-page":"7010","DOI":"10.1128\/IAI.68.12.7010-7017.2000","volume":"68","author":"E Cario","year":"2000","unstructured":"Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun. 2000;68:7010\u20137.","journal-title":"Infect Immun"},{"key":"862_CR19","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1053\/gast.2002.32371","volume":"122","author":"NS Buttar","year":"2002","unstructured":"Buttar NS, Wang KK, Leontovich O, Westcott JY, Pacifico RJ, Anderson MA, et al. Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett\u2019s esophagus. Gastroenterology. 2002;122:1101\u201312.","journal-title":"Gastroenterology"},{"key":"862_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1053\/gast.2002.34244","volume":"123","author":"BS Kaur","year":"2002","unstructured":"Kaur BS, Khamnehei N, Iravani M, Namburu SS, Lin O, Triadafilopoulos G. Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barrett\u2019s esophagus. Gastroenterology. 2002;123:60\u20137.","journal-title":"Gastroenterology"},{"key":"862_CR21","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0016-5085(00)70254-X","volume":"118","author":"VN Shirvani","year":"2000","unstructured":"Shirvani VN, Ouatu-Lascar R, Kaur BS, Omary MB, Triadafilopoulos G. Cyclooxygenase 2 expression in Barrett\u2019s esophagus and adenocarcinoma: ex vivo induction by bile salts and acid exposure. Gastroenterology. 2000;118:487\u201396.","journal-title":"Gastroenterology"},{"key":"862_CR22","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3748\/wjg.v12.i6.928","volume":"12","author":"Y Li","year":"2006","unstructured":"Li Y, Wo JM, Ray MB, Jones W, Su RR, Ellis S, et al. Cyclooxygenase-2 and epithelial growth factor receptor up-regulation during progression of Barrett\u2019s esophagus to adenocarcinoma. World J Gastroenterol. 2006;12:928\u201334.","journal-title":"World J Gastroenterol"},{"key":"862_CR23","first-page":"409","volume":"61","author":"J Majka","year":"2010","unstructured":"Majka J, Rembiasz K, Migaczewski M, Budzynski A, Ptak-Belowska A, Pabianczyk R, et al. Cyclooxygenase-2 (COX-2) is the key event in pathophysiology of Barrett\u2019s esophagus. Lesson from experimental animal model and human subjects. J Physiol Pharmacol. 2010;61:409\u201318.","journal-title":"J Physiol Pharmacol"},{"key":"862_CR24","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.3748\/wjg.v17.i32.3745","volume":"17","author":"I Sheyhidin","year":"2011","unstructured":"Sheyhidin I, Nabi G, Hasim A, Zhang RP, Ainiwaer J, Ma H, et al. Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma. World J Gastroenterol. 2011;17:3745\u201351.","journal-title":"World J Gastroenterol"},{"key":"862_CR25","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/j.1442-2050.2007.00683.x","volume":"20","author":"KR Jaiswal","year":"2007","unstructured":"Jaiswal KR, Morales CP, Feagins LA, Gandia KG, Zhang X, Zhang HY, et al. Characterization of telomerase-immortalized, non-neoplastic, human Barrett\u2019s cell line (BAR-T). Dis Esophagus. 2007;20:256\u201364.","journal-title":"Dis Esophagus"},{"key":"862_CR26","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.4049\/jimmunol.176.5.3070","volume":"176","author":"MD Neal","year":"2006","unstructured":"Neal MD, Leaphart C, Levy R, Prince J, Billiar TR, Watkins S, et al. Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J Immunol. 2006;176:3070\u20139.","journal-title":"J Immunol"},{"key":"862_CR27","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.leukres.2005.05.004","volume":"29","author":"MG Garcia","year":"2005","unstructured":"Garcia MG, Alaniz L, Lopes EC, Blanco G, Hajos SE, Alvarez E. Inhibition of NF-kappaB activity by BAY 11-7082 increases apoptosis in multidrug resistant leukemic T-cell lines. Leuk Res. 2005;29:1425\u201334.","journal-title":"Leuk Res"},{"key":"862_CR28","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1136\/gutjnl-2011-301061","volume":"62","author":"JW Baal van","year":"2013","unstructured":"van Baal JW, Verbeek RE, Bus P, Fassan M, Souza RF, Rugge M, et al. microRNA-145 in Barrett\u2019s oesophagus: regulating BMP4 signalling via GATA6. Gut. 2013;62:664\u201375.","journal-title":"Gut"},{"key":"862_CR29","doi-asserted-by":"crossref","first-page":"RESEARCH0034","DOI":"10.1186\/gb-2002-3-7-research0034","volume":"3","author":"J Vandesompele","year":"2002","unstructured":"Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3:RESEARCH0034.","journal-title":"Genome Biol"},{"key":"862_CR30","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.204","volume":"40","author":"BS Budde","year":"2008","unstructured":"Budde BS, Namavar Y, Barth PG, Poll-The BT, Nurnberg G, Becker C, et al. tRNA splicing endonuclease mutations cause pontocerebellar hypoplasia. Nat Genet. 2008;40:1113\u20138.","journal-title":"Nat Genet"},{"key":"862_CR31","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/jnen\/61.11.1013","volume":"61","author":"M Bsibsi","year":"2002","unstructured":"Bsibsi M, Ravid R, Gveric D, van Noort JM. Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol. 2002;61:1013\u201321.","journal-title":"J Neuropathol Exp Neurol"},{"key":"862_CR32","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1159\/000110455","volume":"20","author":"S Walter","year":"2007","unstructured":"Walter S, Letiembre M, Liu Y, Heine H, Penke B, Hao W, et al. Role of the toll-like receptor 4 in neuroinflammation in Alzheimer\u2019s disease. Cell Physiol Biochem. 2007;20:947\u201356.","journal-title":"Cell Physiol Biochem"},{"key":"862_CR33","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1158\/0008-5472.CAN-10-2833","volume":"71","author":"RY Hsu","year":"2011","unstructured":"Hsu RY, Chan CH, Spicer JD, Rousseau MC, Giannias B, Rousseau S, et al. LPS-induced TLR4 signaling in human colorectal cancer cells increases beta1 integrin-mediated cell adhesion and liver metastasis. Cancer Res. 2011;71:1989\u201398.","journal-title":"Cancer Res"},{"key":"862_CR34","first-page":"475","volume":"31","author":"R Sitarz","year":"2009","unstructured":"Sitarz R, Leguit RJ, de Leng WW, Morsink FH, Polkowski WP, Maciejewski R, et al. Cyclooxygenase-2 mediated regulation of E-cadherin occurs in conventional but not early-onset gastric cancer cell lines. Cell Oncol. 2009;31:475\u201385.","journal-title":"Cell Oncol."},{"key":"862_CR35","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/35014038","volume":"2","author":"K Burns","year":"2000","unstructured":"Burns K, Clatworthy J, Martin L, Martinon F, Plumpton C, Maschera B, et al. Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat Cell Biol. 2000;2:346\u201351.","journal-title":"Nat Cell Biol"},{"key":"862_CR36","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1128\/MCB.26.3.735-742.2006","volume":"26","author":"A Didierlaurent","year":"2006","unstructured":"Didierlaurent A, Brissoni B, Velin D, Aebi N, Tardivel A, Kaslin E, et al. Tollip regulates proinflammatory responses to interleukin-1 and lipopolysaccharide. Mol Cell Biol. 2006;26:735\u201342.","journal-title":"Mol Cell Biol"},{"key":"862_CR37","doi-asserted-by":"publisher","first-page":"7059","DOI":"10.1074\/jbc.M109537200","volume":"277","author":"G Zhang","year":"2002","unstructured":"Zhang G, Ghosh S. Negative regulation of toll-like receptor-mediated signaling by Tollip. J Biol Chem. 2002;277:7059\u201365.","journal-title":"J Biol Chem"},{"key":"862_CR38","doi-asserted-by":"publisher","first-page":"6867","DOI":"10.1038\/sj.onc.1203219","volume":"18","author":"M Karin","year":"1999","unstructured":"Karin M. How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene. 1999;18:6867\u201374.","journal-title":"Oncogene"},{"key":"862_CR39","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1136\/gut.2006.103697","volume":"56","author":"K Dvorak","year":"2007","unstructured":"Dvorak K, Payne CM, Chavarria M, Ramsey L, Dvorakova B, Bernstein H, et al. Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett\u2019s oesophagus. Gut. 2007;56:763\u201371.","journal-title":"Gut"},{"key":"862_CR40","doi-asserted-by":"publisher","first-page":"G1172","DOI":"10.1152\/ajpgi.00065.2009","volume":"297","author":"DM Lim","year":"2009","unstructured":"Lim DM, Narasimhan S, Michaylira CZ, Wang ML. TLR3-mediated NF-{kappa}B signaling in human esophageal epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2009;297:G1172\u201380.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"862_CR41","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1016\/j.molimm.2007.02.007","volume":"44","author":"A Uehara","year":"2007","unstructured":"Uehara A, Fujimoto Y, Fukase K, Takada H. Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines. Mol Immunol. 2007;44:3100\u201311.","journal-title":"Mol Immunol"},{"key":"862_CR42","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/S0002-9440(10)65346-1","volume":"154","author":"JA Jankowski","year":"1999","unstructured":"Jankowski JA, Wright NA, Meltzer SJ, Triadafilopoulos G, Geboes K, Casson AG, et al. Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol. 1999;154:965\u201373.","journal-title":"Am J Pathol"},{"key":"862_CR43","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/ibd.21527","volume":"17","author":"M Fukata","year":"2011","unstructured":"Fukata M, Shang L, Santaolalla R, Sotolongo J, Pastorini C, Espana C, et al. Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis. Inflamm Bowel Dis. 2011;17:1464\u201373.","journal-title":"Inflamm Bowel Dis"},{"key":"862_CR44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1086\/518578","volume":"45","author":"S Macfarlane","year":"2007","unstructured":"Macfarlane S, Furrie E, Macfarlane GT, Dillon JF. Microbial colonization of the upper gastrointestinal tract in patients with Barrett\u2019s esophagus. Clin Infect Dis. 2007;45:29\u201338.","journal-title":"Clin Infect Dis"},{"key":"862_CR45","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1053\/j.gastro.2009.04.046","volume":"137","author":"L Yang","year":"2009","unstructured":"Yang L, Lu X, Nossa CW, Francois F, Peek RM, Pei Z. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology. 2009;137:588\u201397.","journal-title":"Gastroenterology"},{"key":"862_CR46","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1158\/1078-0432.CCR-11-0934","volume":"18","author":"L Yang","year":"2012","unstructured":"Yang L, Francois F, Pei Z. Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and barrett esophagus. Clin Cancer Res. 2012;18:2138\u201344.","journal-title":"Clin Cancer Res"},{"key":"862_CR47","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/j.1440-1746.2009.05854.x","volume":"24","author":"AG Testro","year":"2009","unstructured":"Testro AG, Visvanathan K. Toll-like receptors and their role in gastrointestinal disease. J Gastroenterol Hepatol. 2009;24:943\u201354.","journal-title":"J Gastroenterol Hepatol"},{"key":"862_CR48","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1016\/j.ejca.2004.08.013","volume":"40","author":"A Faried","year":"2004","unstructured":"Faried A, Sohda M, Nakajima M, Miyazaki T, Kato H, Kuwano H. Expression of heat-shock protein Hsp60 correlated with the apoptotic index and patient prognosis in human oesophageal squamous cell carcinoma. Eur J Cancer. 2004;40:2804\u201311.","journal-title":"Eur J Cancer"},{"key":"862_CR49","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00109-007-0176-3","volume":"85","author":"J Ostrowski","year":"2007","unstructured":"Ostrowski J, Mikula M, Karczmarski J, Rubel T, Wyrwicz LS, Bragoszewski P, et al. Molecular defense mechanisms of Barrett\u2019s metaplasia estimated by an integrative genomics. J Mol Med (Berl.). 2007;85:733\u201343.","journal-title":"J Mol Med (Berl.)."},{"key":"862_CR50","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.4049\/jimmunol.166.3.1938","volume":"166","author":"R Dziarski","year":"2001","unstructured":"Dziarski R, Wang Q, Miyake K, Kirschning CJ, Gupta D. MD-2 enables Toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to Gram-positive and Gram-negative bacteria and their cell wall components. J Immunol. 2001;166:1938\u201344.","journal-title":"J Immunol"},{"key":"862_CR51","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.4049\/jimmunol.168.8.4012","volume":"168","author":"HK Lee","year":"2002","unstructured":"Lee HK, Lee J, Tobias PS. Two lipoproteins extracted from Escherichia coli K-12 LCD25 lipopolysaccharide are the major components responsible for Toll-like receptor 2-mediated signaling. J Immunol. 2002;168:4012\u20137.","journal-title":"J Immunol"},{"key":"862_CR52","doi-asserted-by":"publisher","first-page":"25420","DOI":"10.1074\/jbc.M400598200","volume":"279","author":"NL Que-Gewirth","year":"2004","unstructured":"Que-Gewirth NL, Ribeiro AA, Kalb SR, Cotter RJ, Bulach DM, Adler B, et al. A methylated phosphate group and four amide-linked acyl chains in leptospira interrogans lipid A. The membrane anchor of an unusual lipopolysaccharide that activates TLR2. J Biol Chem. 2004;279:25420\u20139.","journal-title":"J Biol Chem"},{"key":"862_CR53","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1189\/jlb.1209775","volume":"87","author":"C Erridge","year":"2010","unstructured":"Erridge C. Endogenous ligands of TLR2 and TLR4: agonists or assistants? J Leukoc Biol. 2010;87:989\u201399.","journal-title":"J Leukoc Biol"},{"key":"862_CR54","doi-asserted-by":"publisher","first-page":"618","DOI":"10.4049\/jimmunol.165.2.618","volume":"165","author":"M Hirschfeld","year":"2000","unstructured":"Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol. 2000;165:618\u201322.","journal-title":"J Immunol"},{"key":"862_CR55","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.cgh.2012.12.011","volume":"11","author":"WK Lo","year":"2013","unstructured":"Lo WK, Chan WW. Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis. Clin Gastroenterol Hepatol. 2013;11:483\u201390.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"862_CR56","first-page":"1692","volume":"91","author":"RC Orlando","year":"1996","unstructured":"Orlando RC. Why is the high grade inhibition of gastric acid secretion afforded by proton pump inhibitors often required for healing of reflux esophagitis? An epithelial perspective. Am J Gastroenterol. 1996;91:1692\u20136.","journal-title":"Am J Gastroenterol"},{"key":"862_CR57","doi-asserted-by":"publisher","first-page":"84","DOI":"10.2174\/138920009787048392","volume":"10","author":"BJ Vesper","year":"2009","unstructured":"Vesper BJ, Jawdi A, Altman KW, Haines GK 3rd, Tao L, Radosevich JA. The effect of proton pump inhibitors on the human microbiota. Curr Drug Metab. 2009;10:84\u20139.","journal-title":"Curr Drug Metab"},{"key":"862_CR58","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1136\/jclinpath-2011-200567","volume":"65","author":"P Pimentel-Nunes","year":"2012","unstructured":"Pimentel-Nunes P, Goncalves N, Boal-Carvalho I, Afonso L, Lopes P, Roncon-Albuquerque R, et al. Decreased Toll-interacting protein and peroxisome proliferator-activated receptor gamma are associated with increased expression of Toll-like receptors in colon carcinogenesis. J Clin Pathol. 2012;65:302\u20138.","journal-title":"J Clin Pathol"},{"key":"862_CR59","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/hel.12008","volume":"18","author":"P Pimentel-Nunes","year":"2013","unstructured":"Pimentel-Nunes P, Goncalves N, Boal-Carvalho I, Afonso L, Lopes P, Roncon-Albuquerque R Jr, et al. Helicobacter pylori induces increased expression of Toll-like receptors and decreased Toll-interacting protein in gastric mucosa that persists throughout gastric carcinogenesis. Helicobacter. 2013;18:22\u201332.","journal-title":"Helicobacter"},{"key":"862_CR60","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1016\/j.cub.2006.09.062","volume":"16","author":"B Brissoni","year":"2006","unstructured":"Brissoni B, Agostini L, Kropf M, Martinon F, Swoboda V, Lippens S, et al. Intracellular trafficking of interleukin-1 receptor I requires Tollip. Curr Biol. 2006;16:2265\u201370.","journal-title":"Curr Biol"},{"key":"862_CR61","doi-asserted-by":"publisher","first-page":"24435","DOI":"10.1074\/jbc.M400059200","volume":"279","author":"Y Katoh","year":"2004","unstructured":"Katoh Y, Shiba Y, Mitsuhashi H, Yanagida Y, Takatsu H, Nakayama K. Tollip and Tom1 form a complex and recruit ubiquitin-conjugated proteins onto early endosomes. J Biol Chem. 2004;279:24435\u201343.","journal-title":"J Biol Chem"},{"key":"862_CR62","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1001\/archsurg.142.6.554","volume":"142","author":"DS Oh","year":"2007","unstructured":"Oh DS, DeMeester SR, Vallbohmer D, Mori R, Kuramochi H, Hagen JA, et al. Reduction of interleukin 8 gene expression in reflux esophagitis and Barrett\u2019s esophagus with antireflux surgery. Arch Surg. 2007;142:554\u20139.","journal-title":"Arch Surg"},{"key":"862_CR63","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/01.sla.0000118751.95179.c6","volume":"239","author":"MM Abdel-latif","year":"2004","unstructured":"Abdel-latif MM, O\u2019Riordan J, Windle HJ, Carton E, Ravi N, Kelleher D, et al. NF-kappaB activation in esophageal adenocarcinoma: relationship to Barrett\u2019s metaplasia, survival, and response to neoadjuvant chemoradiotherapy. Ann Surg. 2004;239:491\u2013500.","journal-title":"Ann Surg"},{"key":"862_CR64","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1136\/gut.51.3.316","volume":"51","author":"RC Fitzgerald","year":"2002","unstructured":"Fitzgerald RC, Abdalla S, Onwuegbusi BA, Sirieix P, Saeed IT, Burnham WR, et al. Inflammatory gradient in Barrett\u2019s oesophagus: implications for disease complications. Gut. 2002;51:316\u201322.","journal-title":"Gut"},{"key":"862_CR65","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1111\/j.1572-0241.2005.41338.x","volume":"100","author":"JM O\u2019Riordan","year":"2005","unstructured":"O\u2019Riordan JM, Abdel-latif MM, Ravi N, McNamara D, Byrne PJ, McDonald GS, et al. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Gastroenterol. 2005;100:1257\u201364.","journal-title":"Am J Gastroenterol"},{"key":"862_CR66","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1158\/0008-5472.CAN-08-3703","volume":"69","author":"K Hormi-Carver","year":"2009","unstructured":"Hormi-Carver K, Zhang X, Zhang HY, Whitehead RH, Terada LS, Spechler SJ, et al. Unlike esophageal squamous cells, Barrett\u2019s epithelial cells resist apoptosis by activating the nuclear factor-kappaB pathway. Cancer Res. 2009;69:672\u20137.","journal-title":"Cancer Res"},{"key":"862_CR67","doi-asserted-by":"publisher","first-page":"e33899","DOI":"10.1371\/journal.pone.0033899","volume":"7","author":"A Lind","year":"2012","unstructured":"Lind A, Siersema PD, Kusters JG, Van der Linden JA, Knol EF, Koenderman L. The immune cell composition in Barrett\u2019s metaplastic tissue resembles that in normal duodenal tissue. PLoS One. 2012;7:e33899.","journal-title":"PLoS One"},{"key":"862_CR68","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nri2707","volume":"10","author":"MT Abreu","year":"2010","unstructured":"Abreu MT. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol. 2010;10:131\u201344.","journal-title":"Nat Rev Immunol"},{"key":"862_CR69","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1128\/MCB.01690-12","volume":"33","author":"KF MacKenzie","year":"2013","unstructured":"MacKenzie KF, Van Den Bosch MW, Naqvi S, Elcombe SE, McGuire VA, Reith AD, et al. MSK1 and MSK2 inhibit lipopolysaccharide-induced prostaglandin production via an interleukin-10 feedback loop. Mol Cell Biol. 2013;33:1456\u201367.","journal-title":"Mol Cell Biol"},{"key":"862_CR70","doi-asserted-by":"crossref","unstructured":"Wittebole X, Castanares-Zapatero D, Laterre PF. Toll-like receptor 4 modulation as a strategy to treat sepsis. Mediators Inflamm. 2010:568396.","DOI":"10.1155\/2010\/568396"},{"key":"862_CR71","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1056\/NEJMoa061355","volume":"355","author":"MM Bertagnolli","year":"2006","unstructured":"Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Solomon SD, Kim K, et al. Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med. 2006;355:873\u201384.","journal-title":"N Engl J Med"},{"key":"862_CR72","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","volume":"343","author":"C Bombardier","year":"2000","unstructured":"Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med. 2000;343:1520\u20138.","journal-title":"N Engl J Med"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-013-0862-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-013-0862-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-013-0862-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-013-0862-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:38:08Z","timestamp":1559083088000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-013-0862-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,17]]},"references-count":72,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["862"],"URL":"https:\/\/doi.org\/10.1007\/s00535-013-0862-6","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,17]]}}}